Updates in Metastatic ER+ Breast Cancer (SERDs, Monaleesa 2, etc.) | Updates in Early Stage ER+ Breast Cancer (SOFT/TEXT, RxPonder, and adjuvant CDK, etc.) | Case Presentations (All Panelists)/Tumor Board Discussion with ER+ Cases | Updates in HER2+ Metastatic Disease (DESTINY 03, etc.) | Updates in Early Stage Triple Negative Disease (KEYNOTE 522, Olympia) | Case Presentations (All Panelists)/Tumor Board Discussion with TNBC/HER2+ Cases
DISTINGUISHED SPEAKERS INCLUDE:
Ruth O'Regan, MD, Chair of Medicine, Charles A. Dewey Professor at the University of Rochester, Physician-in-Chief of Strong Memorial Hospital, Associate Director of Education and Mentoring, Wilmot Cancer Institute at the University of Rochester
Kevin Kalinsky, MD, MS, Acting Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Director of the Glenn Family Breast Center at the Winship Cancer Institute
Andrew Pippas, MD, Medical Director and Director of Clinical Oncology Research, John B. Amos Cancer Center
Jane Meisel, MD, Associate Professor of Hematology and Medical Oncology, Winship Cancer Institute at Emory University
Erika Hamilton, MD, Director, Breast and Gynecologic Cancer Program, Sarah Cannon Research Institute/Tennessee Oncology
Important note: For those who plan to attend in person, GASCO is not restricting attendance at this meeting and welcomes vaccinated and unvaccinated attendees. While not implementing restrictions, given the COVID-19 pandemic and the emergence of the new Omicron variant, both vaccinated and unvaccinated attendees will be required to wear a face mask in all public and open areas of the hotel. GASCO recommends, but will not require, wearing face masks in the meeting room during program sessions. GASCO will have face masks available and will also provide individual bottles of hand sanitizer.
If you have any questions or require assistance please email Karen Beard (Karen.Beard@gasco.us) or Anne Marie Cahill (anne@gasco.us), or call (770) 951-8427.